GV.PA
Price:
$0.0018
Market Cap:
$693.19K
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutio...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2014-04-02
Stock Exchange
PAR
Ticker
GV.PA
According to Genomic Vision S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -96.76% compared to the average of -0.51 of the last 4 quarters.
The mean historical PE Ratio of Genomic Vision S.A. over the last ten years is -8.07. The current -0.02 PE Ratio has changed -79.73% with respect to the historical average. Over the past ten years (40 quarters), GV.PA's PE Ratio was at its highest in in the June 2023 quarter at -0.05. The PE Ratio was at its lowest in in the January 2013 quarter at -34.89.
Average
-8.07
Median
-2.31
Minimum
-34.89
Maximum
-0.39
Discovering the peaks and valleys of Genomic Vision S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 361.20%
Maximum Annual PE Ratio = -0.39
Minimum Annual Increase = -78.35%
Minimum Annual PE Ratio = -34.89
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.73 | -68.39% |
| 2021 | -2.30 | -64.00% |
| 2020 | -6.39 | 256.26% |
| 2019 | -1.79 | 361.20% |
| 2018 | -0.39 | -78.35% |
| 2017 | -1.80 | -22.54% |
| 2016 | -2.32 | -74.29% |
| 2015 | -9.02 | -57.29% |
| 2014 | -21.11 | -39.49% |
The current PE Ratio of Genomic Vision S.A. (GV.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.14
5-year avg
-2.32
10-year avg
-8.07
Genomic Vision S.A.’s PE Ratio is greater than Metrics in Balance N.V. (-2.71), greater than Gour Medical S.A. (-1.67), greater than Pixium Vision S.A. (-1.92), greater than PHAXIAM Therapeutics S.A. (-0.02), less than Safe Orthopaedics S.A. (-0.00), greater than I.ceram S.A. (-0.11), greater than Deinove S.A. (-0.11), less than Neovacs S.A. (-0.00), less than Pharnext S.A. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.71 | $790.30K | |
| -1.67 | $536.27K | |
| -1.92 | $1.16M | |
| -0.02 | $1.01M | |
| -0.00 | $21.89K | |
| -0.11 | $155.73K | |
| -0.11 | $1.13M | |
| -0.00 | $8.10K | |
| -0.00 | $1.19K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomic Vision S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genomic Vision S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genomic Vision S.A.'s PE Ratio?
How is the PE Ratio calculated for Genomic Vision S.A. (GV.PA)?
What is the highest PE Ratio for Genomic Vision S.A. (GV.PA)?
What is the 3-year average PE Ratio for Genomic Vision S.A. (GV.PA)?
What is the 5-year average PE Ratio for Genomic Vision S.A. (GV.PA)?
How does the current PE Ratio for Genomic Vision S.A. (GV.PA) compare to its historical average?